Discovery of XL888: A novel tropane-derived small molecule inhibitor of HSP90
Lead optimization of tropane-derived HTS hits driven by traditional SAR and X-ray crystallography led to the identification of clinical candidate 12i (XL888). With structural guidance, tropane-derived HTS hits were modified to optimize for HSP90 inhibition and a desirable in vivo profile. Through an...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2012-09, Vol.22 (17), p.5396-5404 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!